256 related articles for article (PubMed ID: 34821953)
1. Targeting the Wnt signaling pathway for breast cancer bone metastasis therapy.
Cui J; Chen H; Zhang K; Li X
J Mol Med (Berl); 2022 Mar; 100(3):373-384. PubMed ID: 34821953
[TBL] [Abstract][Full Text] [Related]
2. Wnt signaling in bone metastasis: mechanisms and therapeutic opportunities.
Li X; Yang J; Bao M; Zeng K; Fu S; Wang C; Ye L
Life Sci; 2018 Sep; 208():33-45. PubMed ID: 29969609
[TBL] [Abstract][Full Text] [Related]
3. Wnt signaling pathway: implications for therapy in lung cancer and bone metastasis.
Xi Y; Chen Y
Cancer Lett; 2014 Oct; 353(1):8-16. PubMed ID: 25042867
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer bone metastasis and current small therapeutics.
Cicek M; Oursler MJ
Cancer Metastasis Rev; 2006 Dec; 25(4):635-44. PubMed ID: 17160709
[TBL] [Abstract][Full Text] [Related]
5. Osteolytic metastasis in breast cancer: effective prevention strategies.
Mandal CC
Expert Rev Anticancer Ther; 2020 Sep; 20(9):797-811. PubMed ID: 32772585
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer-derived Dickkopf1 inhibits osteoblast differentiation and osteoprotegerin expression: implication for breast cancer osteolytic bone metastases.
Bu G; Lu W; Liu CC; Selander K; Yoneda T; Hall C; Keller ET; Li Y
Int J Cancer; 2008 Sep; 123(5):1034-42. PubMed ID: 18546262
[TBL] [Abstract][Full Text] [Related]
7. The Wnt inhibitor dickkopf-1: a link between breast cancer and bone metastases.
Mariz K; Ingolf JB; Daniel H; Teresa NJ; Erich-Franz S
Clin Exp Metastasis; 2015 Dec; 32(8):857-66. PubMed ID: 26420587
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer bone metastases: pathogenesis and therapeutic targets.
Brook N; Brook E; Dharmarajan A; Dass CR; Chan A
Int J Biochem Cell Biol; 2018 Mar; 96():63-78. PubMed ID: 29309917
[TBL] [Abstract][Full Text] [Related]
9. Antagonizing miR-218-5p attenuates Wnt signaling and reduces metastatic bone disease of triple negative breast cancer cells.
Taipaleenmäki H; Farina NH; van Wijnen AJ; Stein JL; Hesse E; Stein GS; Lian JB
Oncotarget; 2016 Nov; 7(48):79032-79046. PubMed ID: 27738322
[TBL] [Abstract][Full Text] [Related]
10. Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancer.
Johnson RW; Merkel AR; Page JM; Ruppender NS; Guelcher SA; Sterling JA
Clin Exp Metastasis; 2014 Dec; 31(8):945-59. PubMed ID: 25359619
[TBL] [Abstract][Full Text] [Related]
11. Differential effects on lung and bone metastasis of breast cancer by Wnt signalling inhibitor DKK1.
Zhuang X; Zhang H; Li X; Li X; Cong M; Peng F; Yu J; Zhang X; Yang Q; Hu G
Nat Cell Biol; 2017 Oct; 19(10):1274-1285. PubMed ID: 28892080
[TBL] [Abstract][Full Text] [Related]
12. Wnt pathway in osteosarcoma, from oncogenic to therapeutic.
Cai Y; Cai T; Chen Y
J Cell Biochem; 2014 Apr; 115(4):625-31. PubMed ID: 24190862
[TBL] [Abstract][Full Text] [Related]
13. ABL kinases promote breast cancer osteolytic metastasis by modulating tumor-bone interactions through TAZ and STAT5 signaling.
Wang J; Rouse C; Jasper JS; Pendergast AM
Sci Signal; 2016 Feb; 9(413):ra12. PubMed ID: 26838548
[TBL] [Abstract][Full Text] [Related]
14. Pathogenic role of connective tissue growth factor (CTGF/CCN2) in osteolytic metastasis of breast cancer.
Shimo T; Kubota S; Yoshioka N; Ibaragi S; Isowa S; Eguchi T; Sasaki A; Takigawa M
J Bone Miner Res; 2006 Jul; 21(7):1045-59. PubMed ID: 16813525
[TBL] [Abstract][Full Text] [Related]
15. A cross-species analysis of a mouse model of breast cancer-specific osteolysis and human bone metastases using gene expression profiling.
Sadanandam A; Futakuchi M; Lyssiotis CA; Gibb WJ; Singh RK
BMC Cancer; 2011 Jul; 11():304. PubMed ID: 21774828
[TBL] [Abstract][Full Text] [Related]
16. SREBP-2 aggravates breast cancer associated osteolysis by promoting osteoclastogenesis and breast cancer metastasis.
Jie Z; Xie Z; Xu W; Zhao X; Jin G; Sun X; Huang B; Tang P; Wang G; Shen S; Qin A; Fan S
Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):115-125. PubMed ID: 30394316
[TBL] [Abstract][Full Text] [Related]
17. MiR-454-3p-Mediated Wnt/β-catenin Signaling Antagonists Suppression Promotes Breast Cancer Metastasis.
Ren L; Chen H; Song J; Chen X; Lin C; Zhang X; Hou N; Pan J; Zhou Z; Wang L; Huang D; Yang J; Liang Y; Li J; Huang H; Jiang L
Theranostics; 2019; 9(2):449-465. PubMed ID: 30809286
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer metastasis to bone: mechanisms of osteolysis and implications for therapy.
Kozlow W; Guise TA
J Mammary Gland Biol Neoplasia; 2005 Apr; 10(2):169-80. PubMed ID: 16025223
[TBL] [Abstract][Full Text] [Related]
19. Wnt Signaling in the Development of Bone Metastasis.
Ben-Ghedalia-Peled N; Vago R
Cells; 2022 Dec; 11(23):. PubMed ID: 36497192
[TBL] [Abstract][Full Text] [Related]
20. Skeletal metastasis: treatments, mouse models, and the Wnt signaling.
Valkenburg KC; Steensma MR; Williams BO; Zhong Z
Chin J Cancer; 2013 Jul; 32(7):380-96. PubMed ID: 23327798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
